The description of cardiovascular diseases
The description of cardiovascular diseases
Kung nagsimula na ang pag-inom ng gamot para sa mataas na presyon, hindi ibig sabihin na hindi na maaaring gawin ang karagdagang mga hakbang para palakasin ang katawan sa programa ng therapy. Ang benepisyo ng maingat na mga hakbang na pinagkasunduan ng doktor ay nakakatulong para mapigilan ang paglala ng sakit at maiwasang lumipat ito sa mas seryosong yugto.
>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<
The description of cardiovascular diseases Cardiovascular diseases (including cardiovascular diseases) represent one of the main causes of morbidity and mortality in industrialized countries. This group of diseases includes a variety of disorders that affect the heart and the blood circulatory system. Definition and classification Heart disease refers to pathological conditions, the vessels the function of the heart, the blood, or of both organ systems affect. Among the most important forms: Coronary heart disease (CHD) is A narrowing or occlusion of the coronary arteries, often caused by atherosclerosis, which leads to a reduced blood flow to the heart muscle. Congestive heart failure: A condition in which the heart can no longer pump enough blood in the circulation to meet the metabolic needs of the body. High blood pressure (hypertension): A chronically elevated blood pressure can lead to damage to the blood and organs. Stroke (apoplexy): A sudden interruption of blood flow in the brain, often due to a blood clot or a hemorrhage. Arrhythmias: disturbances of the heart rhythm, which can range from fast to slow, or irregular heartbeats. Atherosclerosis: The deposits of calcification and hardening of the arterial wall as a result of Plaque. Risk factors A number of modifiable and non-modifiable factors increases the risk for the development of cardiovascular disease: Non-modifiable factors: Age (the risk increases with age) Gender (men are often affected earlier than women) Genetic Disposition Modifiable Factors: Smoking Overweight and obesity Lack of exercise Unhealthy diet (high, high in salt, fat and sugar content) Chronic Stress Diabetes mellitus Hyperlipidemia (elevated blood fats) Symptoms The symptomatology varies depending on the disease, but can include the following symptoms: Chest pain or tight (Angina pectoris) Shortness of breath, especially during physical exertion Tiredness and fatigue Dizziness or fainting Heart palpitations or irregular heartbeat Edema (water retention), especially on the legs Diagnostics The diagnosis is made by a combination of: Review of the medical history and physical examination Electrocardiogram (ECG) Echocardiography (ultrasound of the heart) Load tests (e.g., treadmill test) Blood tests (lipid spectrum of blood sugar, inflammatory markers) Coronary angiography for suspected CHD Therapy and prevention The treatment depends on the disease and may include pharmacological, interventional and operative measures. Important drug options are: Antihypertensives (blood pressure lowering) Statins (used to lower cholesterol) Anticoagulants (to prevent blood clots) Beta-blockers and ACE inhibitors (in the case of heart failure, and hypertension) Preventive measures are of paramount importance and include: a healthy diet with lots of fiber, fruits and vegetables regular physical activity Waiver of tobacco consumption Weight control Stress management regular medical examinations for early detection of risk factors Conclusion Cardiovascular diseases remain a major challenge for the health system. Through a consistent prevention, early diagnosis and adequate therapy, however, the risk is significantly lower, and the quality of life and life expectancy of the Affected significantly improve. If you want, I can make certain sections in more detail or further aspects!
Diuretiko (Diuretika) ay nagpapataas ng pag-ihi ng katawan, na nagreresulta sa pagbaba ng presyon ng dugo. Simpleng paliwanag: Ang tuloy-tuloy na pag-ihi ng katawan ay nagdudulot ng pagbaba ng dami ng plasma sa dugo at sa gayon ay mas kaunting likido sa mga ugat — bumababa ang presyon sa mga pader ng ugat. The description of cardiovascular diseases. Ginagamit ito bilang biologically active na pampadagdag sa pagkain — dagdag na pinagmumulan ng mga bitamina — B2, B6, C, mga organikong asido — mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6.
The national project of the fight against cardiovascular diseases
Catheter Ablation due to cardiovascular diseases
Vitamin for high blood pressure
Heart disease symptoms and causes
https://hd.platypwnies.de/s/lwZioFyXT9
https://doc.interscalar.eu/s/ojA2sW_Db
Ang mga modernong gamot sa pag-imprenta ay hinahati sa 10 iba't ibang grupo ayon sa kanilang mekanismo ng pagkilos. Pagkatapos suriin ng doktor ang mga reklamo ng pasyente at ang resulta ng mga pagsusuri, nagrereseta siya ng isa o higit pang gamot, na hindi dapat baguhin nang mag-isa. Ang mga gamot sa puso at daluyan ng dugo ay hindi kabilang sa mga puwedeng irekomenda sa kaibigan. Ang maling desisyon ay maaaring magdulot ng malungkot na kahihinatnan. Lahat ng gamot na pampababa ng presyon ng dugo ay kailangan ng reseta. Sa artikulong ito, tinitingnan natin ang kanilang modernong klasipikasyon base sa mga aktibong sangkap at sa paraan ng epekto nito sa katawan.
Obesity and cardiovascular disease: A critical connection Obesity, as a pathologically increased percentage of body fat, defined as having a Body Mass Index (BMI) of ≥30 kg/m 2 represents a worldwide increasing health problem. Numerous studies have shown a close connection between obesity and an increased risk for cardiovascular disease (CVD), including coronary heart disease (CHD), congestive heart failure, stroke, and arterial hypertension. Pathophysiological Mechanisms The connection between obesity and CVD is mediated by multiple pathophysiological processes: Metabolic Syndrome. Obesity is often associated with insulin resistance, impaired glucose tolerance, dyslipidemia (elevated triglycerides, low HDL-cholesterol), and hypertension. These factors, together with the so-called metabolic syndrome, which increases the cardiovascular risk is significant form. Inflammatory reactions. Adipöses tissue, in particular visceral fat, acts as an endocrine-active Organ and secretes Pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and Interleukin‑6 (IL‑6). Chronic inflammatory processes promote atherosclerosis formation. Endothelial dysfunction. Adipocytes influence the production of Adipozytokinen (e.g., Adiponectin, Leptin), which leads to disruption of the vascular endothelial function and vasodilation is impaired. Mechanical Stress. Increased body weight increases the work load of the heart, which can lead to left ventricular hypertrophy, and later of heart failure. Epidemiological Data According to the WHO estimates, over 650 million adults worldwide suffer from obesity. Epidemiological studies show: An increase in BMI of 5 kg/m 2 is associated with a doubling of the risk for coronary heart disease. In obese patients, the risk of stroke is increased by 40-60%. Obesity is associated in 70% of cases with arterial hypertension. Clinical Implications A weight reduction of 5-10% of initial body weight results in obese persons to a significant improvement in metabolic parameters: Lowering blood pressure Normalization of blood glucose levels Improvement of the lipid profile Reduction of inflammatory markers Prevention and therapy A multimodal approach for the prevention and treatment of obesity-associated cardiovascular diseases is essential: Diet: low-calorie, fiber-rich diet with a reduced content of saturated fatty acids and sugar. Movement therapy: at least 150 minutes of moderate physical activity per week. Drug therapy: in case of increased cardiovascular risk drugs for lowering blood pressure, lowering cholesterol or blood sugar control is necessary. Bariatric surgery for severe obesity (BMI≥40 kg/m 2 ) or BMI≥35 kg/m 2 with co-morbidities, the operating weight reduction in life can have the effect of increasing. Conclusion Obesity is disease a major, modifiable risk factor for cardiovascular disease. The early identification of obese patients, and a targeted Intervention for weight reduction can reduce the cardiovascular risk and the quality of life and life expectancy improve. Interdisciplinary care is of paramount importance.